NCT06883344Recruiting
Automated Insulin for Management of Intrapartum Glycemia
Automated Insulin for Management of Intrapartum Glycemia (AIMING): a Multicenter Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 13 Jul 2026
Brief summary (registry, in English)
The goal of this clinical trial is learn if automated insulin delivery (AID) systems can be used for glucose management during labor/delivery for pregnant people with type 1 diabetes (T1D). The main questions this study aims to answer are * What are the neonatal glycemic outcomes with use of AID systems during labor/delivery? * Do patients report higher birth satisfaction with use of AID systems during labor/delivery? * Are glycemic parameters like time-in-range (TIR) better with use of AID systems during labor/delivery? Researchers will compare AID systems to intravenous (IV) insulin (the current standard of care for glucose management during labor/delivery) by randomly assigning participants to one or the other.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- First submitted
- 12 Mar 2025
- Start date
- 5 Dec 2025
- Primary completion date
- 31 Dec 2028
- Lead sponsor
- University of California, San Francisco
- Diseases
- Type 1 diabetes
- NCT number
- NCT06883344
What you commit to
- Study type: Interventional
- Planned participants: 150
- From 5 Dec 2025 to the primary completion date, 31 Dec 2028
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Physical or psychological disease likely to interfere with the conduct of the study and/or the ability to participate in own healthcare
Lab values
- Use of medications known to interfere with glucose metabolism
Other
- Multifetal gestation
- Planned cesarean delivery
- Intrauterine fetal demise
Who the study is looking for
- Currently pregnant at ≥ 34 weeks
- Known diagnosis of type 1 diabetes ≥ 1 year
- Use of commercially available AID system since at least 28 weeks gestation
- Singleton pregnancy
- English- or Spanish-speaking
Age in the registry: 18 years to 55 years · Sex: Female · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of California, Los Angeles Coordinator of this site? Confirm its status | Los Angeles | United States | Recruiting |
| University of California San Diego Coordinator of this site? Confirm its status | San Diego | United States | Recruiting |
| University of California San Francisco Coordinator of this site? Confirm its status | San Francisco | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.